All lobbying filings

McGuirewoods Consulting (A Subsidiary of McGuirewoods LLP)

McGuirewoods Consulting (A Subsidiary of McGuirewoods LLP) filed a Q4 report for Osteal Therapeutics, Inc. on January 12, 2026, reporting $30,000 in lobbying income.

Lobbying for Osteal Therapeutics, Inc. · Biopharmaceutical Company

As filed: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) for OSTEAL THERAPEUTICS, INC.

All filings by McGuirewoods Consulting (A Subsidiary of McGuirewoods LLP) · Everything Osteal Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 12, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

General federal government relations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.